TEVETEN

Teveten Adverse Events Reported to the FDA Over Time

How are Teveten adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Teveten, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Teveten is flagged as the suspect drug causing the adverse event.

Most Common Teveten Adverse Events Reported to the FDA

What are the most common Teveten adverse events reported to the FDA?

Dizziness	30 (2.84%)
Cerebrovascular Accident	28 (2.65%)
Dyspnoea	26 (2.46%)
Fall	21 (1.99%)
Hypertension	21 (1.99%)
Myocardial Infarction	18 (1.7%)
Hypotension	15 (1.42%)
Renal Failure	14 (1.33%)
Chronic Sinusitis	13 (1.23%)
Diarrhoea	13 (1.23%)
Asthenia	12 (1.14%)
	Show More
Loss Of Consciousness	12 (1.14%)
Syncope	12 (1.14%)
Drug Exposure During Pregnancy	11 (1.04%)
Malaise	11 (1.04%)
Blood Pressure Increased	10 (.95%)
Condition Aggravated	10 (.95%)
Cough	10 (.95%)
Arrhythmia	9 (.85%)
Blood Pressure Systolic Increased	9 (.85%)
Dysphonia	9 (.85%)
Intestinal Obstruction	9 (.85%)
Hypertensive Crisis	8 (.76%)
Hypoperfusion	8 (.76%)
Nausea	8 (.76%)
Bradycardia	7 (.66%)
Caudal Regression Syndrome	7 (.66%)
Drug Ineffective	7 (.66%)
Ovarian Cancer	7 (.66%)
Pain	7 (.66%)
Pulmonary Embolism	7 (.66%)
Acute Coronary Syndrome	6 (.57%)
Acute Myocardial Infarction	6 (.57%)
Cardiogenic Shock	6 (.57%)
Fatigue	6 (.57%)
Headache	6 (.57%)
Intra-uterine Death	6 (.57%)
Left Ventricular Failure	6 (.57%)
Pain In Extremity	6 (.57%)
Pharyngitis	6 (.57%)
Pneumonia	6 (.57%)
Pulmonary Hypoplasia	6 (.57%)
Road Traffic Accident	6 (.57%)
Angina Pectoris	5 (.47%)
Blood Potassium Decreased	5 (.47%)
Brain Stem Infarction	5 (.47%)
C-reactive Protein Increased	5 (.47%)
Caesarean Section	5 (.47%)
Fungal Infection	5 (.47%)
Gait Disturbance	5 (.47%)
Hyperhidrosis	5 (.47%)
Metastases To Large Intestine	5 (.47%)
Myalgia	5 (.47%)
Overdose	5 (.47%)
Refusal Of Treatment By Patient	5 (.47%)
Suicide Attempt	5 (.47%)
Tachycardia	5 (.47%)
Vision Blurred	5 (.47%)
Abdominal Adhesions	4 (.38%)
Abdominal Neoplasm	4 (.38%)
Anaemia	4 (.38%)
Angioedema	4 (.38%)
Anxiety	4 (.38%)
Blood Pressure Decreased	4 (.38%)
Bundle Branch Block Left	4 (.38%)
Cholelithiasis	4 (.38%)
Chronic Obstructive Pulmonary Disea...	4 (.38%)
Circulatory Collapse	4 (.38%)
Confusional State	4 (.38%)
Hemiplegia	4 (.38%)
Hypoaesthesia	4 (.38%)
Intraocular Pressure Test Abnormal	4 (.38%)
Lip Oedema	4 (.38%)
Metastases To Pleura	4 (.38%)
Mitral Valve Incompetence	4 (.38%)
Myocardial Ischaemia	4 (.38%)
Oral Pain	4 (.38%)
Renal Failure Acute	4 (.38%)
Respiratory Tract Infection	4 (.38%)
Sinus Bradycardia	4 (.38%)
Stillbirth	4 (.38%)
Sudden Death	4 (.38%)
Abasia	3 (.28%)
Abdominal Pain Upper	3 (.28%)
Alcoholic Seizure	3 (.28%)
Asthma	3 (.28%)
Atrial Fibrillation	3 (.28%)
Bronchospasm	3 (.28%)
Cardiomegaly	3 (.28%)
Cellulitis	3 (.28%)
Cold Sweat	3 (.28%)
Completed Suicide	3 (.28%)
Death	3 (.28%)
Depression	3 (.28%)
Drug Interaction	3 (.28%)
Dysstasia	3 (.28%)
Fear	3 (.28%)
Feeling Abnormal	3 (.28%)
Femur Fracture	3 (.28%)
Foetal Disorder	3 (.28%)
Gastrointestinal Disorder	3 (.28%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Teveten, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Teveten is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Teveten

What are the most common Teveten adverse events reported to the FDA?

Neurological	74 (7.01%)
Respiratory	56 (5.3%)
Central Nervous System Vascular	43 (4.07%)
Coronary Artery	42 (3.98%)
Infections - Pathogen Unspecified	37 (3.5%)
Cardiac Arrhythmias	36 (3.41%)
Decreased And Nonspecific Blood Pre...	35 (3.31%)
Injuries	34 (3.22%)
Vascular Hypertensive	29 (2.75%)
Cardiac And Vascular Investigations	28 (2.65%)
Gastrointestinal Signs	23 (2.18%)
	Show More
Renal Disorders	22 (2.08%)
Heart Failures	17 (1.61%)
Metastases	17 (1.61%)
Anxiety Disorders	14 (1.33%)
Chemical Injury And Poisoning	13 (1.23%)
Gastrointestinal Motility And Defec...	13 (1.23%)
Bone And Joint Injuries	12 (1.14%)
Therapeutic And Nontherapeutic Effe...	12 (1.14%)
Bronchial Disorders	11 (1.04%)
Musculoskeletal And Connective Tiss...	11 (1.04%)
Abortions And Stillbirth	10 (.95%)
Hematology Investigations	10 (.95%)
Muscle	10 (.95%)
Oral Soft Tissue Conditions	10 (.95%)
Gastrointestinal Stenosis And Obstr...	9 (.85%)
Reproductive Neoplasms Female Malig...	9 (.85%)
Skin Appendage Conditions	9 (.85%)
Fatal Outcomes	8 (.76%)
Lifestyle Issues	8 (.76%)
Medication Errors	8 (.76%)
Neurological, Special Senses And Ps...	8 (.76%)
Suicidal And Self-injurious Behavio...	8 (.76%)
Viral Infectious	8 (.76%)
Hepatobiliary	7 (.66%)
Musculoskeletal And Connective Tiss...	7 (.66%)
Myocardial	7 (.66%)
Pulmonary Vascular	7 (.66%)
Water, Electrolyte And Mineral	7 (.66%)
Angiedema And Urticaria	6 (.57%)
Cardiac Valve	6 (.57%)
Epidermal And Dermal Conditions	6 (.57%)
Headaches	6 (.57%)
Joint	6 (.57%)
Lower Respiratory Tract Disorders	6 (.57%)
Movement Disorders	6 (.57%)
Neuromuscular	6 (.57%)
Respiratory Disorders Congenital	6 (.57%)
Seizures	6 (.57%)
Vision	6 (.57%)
Cardiac Disorder Signs	5 (.47%)
Cranial Nerve Disorders	5 (.47%)
Electrolyte And Fluid Balance Condi...	5 (.47%)
Fetal Complications	5 (.47%)
Fungal Infectious	5 (.47%)
Gallbladder	5 (.47%)
Miscellaneous And Site Unspecified ...	5 (.47%)
Obstetric And Gynecological Therape...	5 (.47%)
Protein And Chemistry Analyses	5 (.47%)
Upper Respiratory Tract Disorders	5 (.47%)
Anemias Nonhemolytic And Marrow Dep...	4 (.38%)
Bacterial Infectious	4 (.38%)
Deliria	4 (.38%)
Gastrointestinal Conditions	4 (.38%)
Gastrointestinal Inflammatory Condi...	4 (.38%)
Peritoneal And Retroperitoneal Cond...	4 (.38%)
Pregnancy, Labour, Delivery And Pos...	4 (.38%)
Schizophrenia And Other Psychotic	4 (.38%)
Allergic Conditions	3 (.28%)
Cardiac Therapeutic Procedures	3 (.28%)
Depressed Mood Disorders	3 (.28%)
Glucose Metabolism Disorders	3 (.28%)
Mental Impairment	3 (.28%)
Physical Examination Topics	3 (.28%)
Reproductive Neoplasms Male Maligna...	3 (.28%)
Respiratory And Mediastinal Neoplas...	3 (.28%)
Retina, Choroid And Vitreous Hemorr...	3 (.28%)
Vascular Inflammations	3 (.28%)
Vascular Therapeutic Procedures	3 (.28%)
Aneurysms And Artery Dissections	2 (.19%)
Appetite And General Nutritional	2 (.19%)
Arteriosclerosis, Stenosis, Vascula...	2 (.19%)
Body Temperature Conditions	2 (.19%)
Bone Disorders	2 (.19%)
Cardiac And Vascular Disorders Cong...	2 (.19%)
Congenital And Hereditary	2 (.19%)
Diabetic Complications	2 (.19%)
Enzyme	2 (.19%)
Exocrine Pancreas Conditions	2 (.19%)
Eye	2 (.19%)
Gastrointestinal Neoplasms Malignan...	2 (.19%)
Gastrointestinal Therapeutic Proced...	2 (.19%)
Hepatic And Hepatobiliary	2 (.19%)
Inner Ear And Viiith Cranial Nerve	2 (.19%)
Leukemias	2 (.19%)
Lipid Analyses	2 (.19%)
Lipid Metabolism	2 (.19%)
Musculoskeletal And Connective Tiss...	2 (.19%)
Ocular Infections, Irritations And ...	2 (.19%)
Product Quality Issues	2 (.19%)
Renal And Urinary Tract Neoplasms M...	2 (.19%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Teveten, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Teveten is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.